Psychiatry and Neurology, Neurology · Columbia, SC
NPI
1104005941
Since 2007
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2601 Millwood Ave
Columbia, SC, 29205
Phone (803) 788-0038
Groups this clinician bills Medicare through
Medicare paid, 2024
$265K
9,415 services
Medicare patients, 2024
259
Average age 67
Drug cost, 2024
$2.5M
13,328 prescriptions
Company payments, 2025
$2,103
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Eleanya Ogburu-Ogbonnaya was code J1010 (injection, methylprednisolone acetate, 1 mg), 3,281 times for 23 patients. In total Eleanya Ogburu-Ogbonnaya billed 9,415 services in 55 codes, and Medicare paid $265K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-09-25.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 3,281 | 23 | $0.10 | $321 |
| 99214 Office E&M - Established | Office | 939 | 130 | $87.17 | $82K |
| G3002 Chronic pain management and treatment, monthly bundle including, diagnosis; assessment and monitoring; administration of a validated pain rating scale or tool; the development, implementation, revision, and/or maintenance of a person-centered care plan tha | Office | 925 | 129 | $58.47 | $54K |
| 80307 Drug Tests | Office | 678 | 120 | $59.56 | $40K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 442 | 174 | $46.22 | $20K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 160 | 84 | $35.74 | $5,719 |
| 99213 Office E&M - Established | Office | 122 | 54 | $60.39 | $7,367 |
| 99487 Chronic, Principal, and Transitional Care Management | Office | 60 | 32 | $99.42 | $5,965 |
| 97112 PT Treatment | Office | 36 | 15 | $22.36 | $805 |
| 92540 Vision, Hearing, and Speech Services | Office | 29 | 29 | $80.35 | $2,330 |
| 92547 Vision, Hearing, and Speech Services | Office | 28 | 28 | $7.69 | $215 |
| 92546 Vision, Hearing, and Speech Services | Office | 28 | 28 | $96.34 | $2,697 |
| 93922 Duplex Scan - Extremity Arteries | Office | 26 | 25 | $59.86 | $1,556 |
| 95921 Electrical Nerve Conductivity | Office | 25 | 25 | $65.26 | $1,632 |
| 95923 Electrical Nerve Conductivity | Office | 25 | 25 | $90.01 | $2,250 |
By year: 2022 $300K for 7,637 services; 2023 $273K for 6,479 services; 2024 $265K for 9,415 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80307 Drug Tests | 678 | 120 | $59.56 | $40K |
| 36415 Venipuncture Blood Collection | 18 | 16 | $8.65 | $156 |
| 85025 Blood Count | 17 | 15 | $7.61 | $129 |
| 80053 Clinical Chemistry | 15 | 13 | $10.35 | $155 |
Medicare prescription drug claims, 2024
In 2024, the drug Eleanya Ogburu-Ogbonnaya prescribed most often to Medicare patients was Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen), with 2,673 prescriptions and refills. In total Eleanya Ogburu-Ogbonnaya wrote 13,328 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 2,673 | 2,673 | 299 | $174K |
| Gabapentin Generic | 938 | 994 | 168 | $10K |
| Baclofen Generic | 843 | 1,085 | 222 | $12K |
| Morphine Sulfate Er Morphine Sulfate | 651 | 651 | 83 | $20K |
| Xtampza Er Oxycodone Myristate | 633 | 633 | 95 | $338K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 395 | 395 | 57 | $11K |
| Oxycontin Oxycodone Hcl | 321 | 321 | 41 | $197K |
| Pregabalin Generic | 318 | 330 | 62 | $10K |
| Ibuprofen Generic | 291 | 293 | 66 | $3,353 |
| Methadone Hcl Generic | 288 | 288 | 43 | $5,790 |
| Meloxicam Generic | 287 | 301 | 59 | $628 |
| Duloxetine Hcl Generic | 287 | 327 | 80 | $2,724 |
| Topiramate Generic | 266 | 330 | 70 | $1,092 |
| Linzess Linaclotide | 264 | 291 | 82 | $157K |
| Trazodone Hcl Generic | 256 | 283 | 57 | $657 |
Brand drugs: 2,251 claims; generic drugs: 11,063 claims; opioid claims: 5,735.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Eleanya Ogburu-Ogbonnaya $2,103 ($2,103 in general payments such as food, travel and fees) from 26 companies. The largest payer was Forte Bio-Pharma LLC with $335.
| Company | Payments | Amount |
|---|---|---|
| Forte Bio-Pharma LLC | 12 | $335 |
| Teva Pharmaceuticals USA, Inc. TEVA | 13 | $239 |
| Neurocrine BioSciences, Inc. NBIX | 7 | $198 |
| Lundbeck LLC | 7 | $196 |
| Zavation Medical Products, LLC | 1 | $189 |
| Pfizer Inc. PFE | 8 | $138 |
| Alexion Pharmaceuticals, Inc. AZN | 4 | $117 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 3 | $92.99 |
| EMD Serono, Inc. MRK.DE | 4 | $84.1 |
| Axsome Therapeutics, Inc. AXSM | 4 | $79.47 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.